Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a rare brain condition (posterior reversible encephalopathy syndrome) in patients who have developed high levels of acids in the blood (diabetic ketoacidosis) - Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a rare brain condition (posterior reversible encephalopathy syndrome) in patients who have developed high levels of acids in the blood (diabetic ketoacidosis)

Additional Information

Field	Value
Data last updated	October 22, 2024
Metadata last updated	October 22, 2024
Created	October 22, 2024
Format	HTML
License	Open Government Licence - Canada
Has views	False
Id	4e746b57-b7be-4c6b-a562-e367aebdfb03
Package id	2156f8ee-a118-4652-9fdd-cb1dff18526f
Position	1
State	active